3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
46
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
25
Multiple Myeloma
20
Recurrence
19
Lymphoma, Non-Hodgkin
16
Lymphoma
15
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma, B-Cell
13
Hematologic Neoplasms
12
Ovarian Neoplasms
10
Melanoma
10
Leukemia
10
Myeloproliferative Disorders
9
Burkitt Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
8
Hodgkin Disease
8
Pancreatic Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasms
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Breast Neoplasms
6
Neoplasm Metastasis
5
Lymphoma, Mantle-Cell
5
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
fludarabine
×
90 days
×
Clear all
No trials found.